Noden Pharma USA Inc is a pharmaceutical company based in Orlando, FL that specializes in the development and production of TEKTURNA, a medication used to manage blood pressure. TEKTURNA is a direct renin inhibitor that works by limiting the formation of angiotensin I, a key component of the renin-angiotensin-aldosterone system. The company offers TEKTURNA in tablet form and provides important safety information and dosing instructions for patients.
TEKTURNA is indicated for the treatment of hypertension in adults and pediatric patients weighing 50kg or greater who are at least 6 years of age. The safety and effectiveness of TEKTURNA have been established in pediatric patients 6 years of age and older weighing 20 kg or more. However, TEKTURNA is not approved for use in patients 6 years of age and older weighing 20 kg to less than 50 kg due to the lack of an appropriate dosage form. TEKTURNA HCT, a combination medication of aliskiren and hydrochlorothiazide, is also available for the treatment of hypertension in adults. It is important to note that TEKTURNA and TEKTURNA HCT should be discontinued as soon as pregnancy is detected, as they can cause fetal toxicity.
Generated from the website